By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Altimmune shares cratered nearly 60% on Thursday after its experimental obesity drug did not significantly improve liver ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss in lean muscle.

There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

(Yicai) June 27 -- China's drug regulator is expected to approve the country's first domestically produced glucagon-like ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

(Yicai) June 23 -- The efficacy of a glucagon-like peptide-1 weight-loss agonist developed by Chinese pharmaceutical firm ...